Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Increase of Ki-67 index in NEN over time in relation to progression and a potential influence on prognosis is scarcely studied.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Holmager P
Authors: Holmager P, Langer S, Federspiel B, Willemoe G, Garbyal R,
Keywords: Ki-67 index, Prognosis, Mortality,
Introduction: Surgery is the principal treatment for loco-regional gastroenteropancreatic (GEP) neuroendocrine tumors (NET). However, whether surgery is beneficial in high-grade neuroendocrine neoplasms (NEN) and mixed neuroendocrine-non neuroendocrine neoplasms (MiNEN) is not known.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Pommergaard H
Authors: Pommergaard H, Nielsen K, Sorbye H, Federspiel B, Tabaksblat E,
Keywords: surgery, neuroendocrine carcinoma, MiNEN, neuroendocrine neoplasms, survival, gastroenteropancreatic,
#1892 Feasibility and Implication of Routine NGS Analysis in Neuroendocrine Carcinomas
Introduction: Neuroendocrine carcinomas (NECs) may arise from any organ system, exhibit various degree of differentiation and have Ki67 indices ranging from 21-100%. After first-line platin based chemotherapy, no standard treatment exists.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Knigge U, Federspiel B, Andreassen M, Kjær A, Langer S,
Keywords: neuroendocrine, neuroendocrine neoplasms, neuroendocrine carcinoma, ngs, genes, mutation, ki67, tp53, kras, braf, pik3a, pten,
#1830 Increase of the Ki67 Proliferation Index over Time in Patients with Neuroendocrine Neoplasms
Introduction: Whether the Ki67 index increases over time in relation to progression is scarcely studied.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Holmager P, Langer S, Federspiel B, Andreassen M, Kjær A,
Keywords: neuroendocrine, Ki67, progression,
Introduction: Accurate grading of patients with neuroendocrine tumors (NETs) is essential for risk stratification and optimal choice of therapy. Currently, WHO grading is based on histo-pathologically assessed degree of tumor proliferation.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Kjaer A
Authors: Binderup T, Johnbeck C, Loft A, Berthelsen A, Federspiel B,